Lupus clinical trials in California
26 studies for Lupus are looking for participants at sites in California.
Cities in California
- San Diego8 studies
- Santa Monica7 studies
- Buena Park7 studies
- Los Angeles7 studies
- Fullerton4 studies
- San Francisco4 studies
- Upland3 studies
- Sacramento3 studies
- San Leandro3 studies
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Fontana
- Research Site, La Jolla
- Research Site, La Palma
- and 3 more
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 13, 2026 · NCT07430306A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Wallace & Lee Center, Beverly Hills
- Arthritis & Osteoporosis Medical Center, Inc - La Palma, La Palma
- University of California San Diego, San Diego
- and 3 more
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Nov 12, 2026 · NCT07409181Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345Study of Afimetoran in Adults With Cutaneous Lupus Erythematosus
- University Clinical Trials, San Diego
RecruitingPhase 2/3
Ages 16 and older · All sexes · Updated Nov 10, 2026 · NCT07881120Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Providence Medical Center, Burbank
- Advanced Medical Research, La Palma
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Nov 9, 2026 · NCT06133972A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Inland Rheumatology Clinical Trials, Inc., Upland
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 4, 2026 · NCT07355218A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Dermatology Research Associates - 300204025, Los Angeles
- Cohen Medical Centers, Thousand Oaks
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 4, 2026 · NCT07332481A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- David S Hallegua MD A Professional Corporation, Beverly Hills
- Southland Arthritis and Osteoporosis Medical Center Inc dba Southland Arthritis, Hemet
- Advanced Medical Research, La Palma
- and 5 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 3, 2026 · NCT07438496A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0054, La Jolla
- Local Institution - 0001, La Palma
- Local Institution - 0071, Los Angeles
- and 1 more
RecruitingObservational study
Ages 16 and older · All sexes · Updated Nov 2, 2026 · NCT07175285A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Nov 2, 2026 · NCT07085104A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50737, Beverly Hills
- Sl0044 50775, Beverly Hills
- Sl0044 50257, La Jolla
- and 6 more
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Nov 2, 2026 · NCT06617325Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Research Site, Fullerton
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Oct 28, 2026 · NCT07201558Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- University of California San Francisco - Zuckerberg San Francisco General, San Francisco
RecruitingPhase 1
Ages 18 to 60 · All sexes · Updated Oct 27, 2026 · NCT06975787A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- UC San Diego Health, La Jolla
- Stanford University Medical Center, Redwood City
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Oct 26, 2026 · NCT06925542A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Solace Research /ID# 279155, Tustin
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Oct 20, 2026 · NCT07607964A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, La Jolla
- Research Site, Sacramento
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Oct 19, 2026 · NCT06916806RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of California Irvine, Orange
- UC Davis Health, Sacramento
RecruitingPhase 1/2
Ages 12 to 65 · All sexes · Updated Oct 6, 2026 · NCT06121297An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Los Angeles
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 30, 2026 · NCT05835310A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Wallace Rheumatic Studies Center, Beverly Hills
- Kaiser Permanente Fontana, Fontana
- Providence Medical Foundation, Fullerton
- and 2 more
RecruitingPhase 2
Ages 12 to 70 · All sexes · Updated Sep 14, 2026 · NCT07570862A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, San Francisco
- Research Site, Stanford
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Sep 10, 2026 · NCT06897930FT839 in Autoimmune Diseases
- Providence Medical Foundation, Fullerton
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Sep 2, 2026 · NCT07800871Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- University of California, Los Angeles, Los Angeles
- University of California: San Diego, San Diego
RecruitingPhase 3
Ages 55 and older · All sexes · Updated Aug 20, 2026 · NCT05799378Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
- Carewell Arthritis Center, Apple Valley
- Attune Health Research Inc, Beverly Hills
- Covina Arthritis Clinic, Covina
- and 4 more
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Jul 20, 2026 · NCT07237659A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- US06-0, La Palma
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Jun 2, 2026 · NCT06625671A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Wallace Rheumatic Center, Beverly Hills
- Providence Medical Foundation, Fullerton
- University of California Irvine, Irvine
- and 2 more
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Wallace Rheumatic Studies Center, Beverly Hills
- UCLA, Los Angeles
RecruitingObservational study
Ages 18 to 110 · All sexes · Updated Apr 15, 2026 · NCT05934149From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.